Cargando…
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877431/ https://www.ncbi.nlm.nih.gov/pubmed/29315292 http://dx.doi.org/10.1038/bjc.2017.469 |
_version_ | 1783310696787738624 |
---|---|
author | Hottinger, A F Ben Aissa, A Espeli, V Squiban, D Dunkel, N Vargas, M I Hundsberger, T Mach, N Schaller, K Weber, D C Bodmer, A Dietrich, P-Y |
author_facet | Hottinger, A F Ben Aissa, A Espeli, V Squiban, D Dunkel, N Vargas, M I Hundsberger, T Mach, N Schaller, K Weber, D C Bodmer, A Dietrich, P-Y |
author_sort | Hottinger, A F |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5877431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-58774312018-04-05 Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma Hottinger, A F Ben Aissa, A Espeli, V Squiban, D Dunkel, N Vargas, M I Hundsberger, T Mach, N Schaller, K Weber, D C Bodmer, A Dietrich, P-Y Br J Cancer Corrigendum Nature Publishing Group 2018-03-20 2018-01-09 /pmc/articles/PMC5877431/ /pubmed/29315292 http://dx.doi.org/10.1038/bjc.2017.469 Text en Copyright © 2018 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Corrigendum Hottinger, A F Ben Aissa, A Espeli, V Squiban, D Dunkel, N Vargas, M I Hundsberger, T Mach, N Schaller, K Weber, D C Bodmer, A Dietrich, P-Y Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma |
title | Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma |
title_full | Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma |
title_fullStr | Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma |
title_full_unstemmed | Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma |
title_short | Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma |
title_sort | phase i study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877431/ https://www.ncbi.nlm.nih.gov/pubmed/29315292 http://dx.doi.org/10.1038/bjc.2017.469 |
work_keys_str_mv | AT hottingeraf phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma AT benaissaa phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma AT espeliv phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma AT squiband phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma AT dunkeln phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma AT vargasmi phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma AT hundsbergert phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma AT machn phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma AT schallerk phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma AT weberdc phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma AT bodmera phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma AT dietrichpy phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma |